ONCOETHIX GMBH
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 20 Total Citation Count
- Sep 27, 2013 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0281,642 METHODS OF TREATING ACUTE MYELOID LEUKEMIA OR ACUTE LYMPHOID LEUKEMIA USING PHARMACEUTICAL COMPOSITIONS CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDSAug 28, 15Oct 05, 17[A61K]
2017/0095,484 METHOD OF TREATING RESISTANT NON-HODGKIN LYMPHOMA, MEDULLOBLASTOMA, AND/OR ALK+NON-SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDSMay 01, 15Apr 06, 17[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9901583 Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compoundsJun 12, 15Feb 27, 18[A61K]
9820992 Method of treating non-small-cell lung cancer using pharmaceutical formulation containing thienotriazolodiazepine compoundsNov 26, 14Nov 21, 17[A61K]
9795612 Pharmaceutical formulation containing thienotriazolodiazepine compoundsAug 01, 14Oct 24, 17[A61K]
9757385 Method of treating leukemia using pharmaceutical formulation containing thienotriazolodiazepine compoundsNov 26, 14Sep 12, 17[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0158,246 METHOD OF TREATING DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) USING A BET-BROMODOMAIN INHIBITORAbandonedAug 06, 14Jun 09, 16[A61K]
2014/0107,107 PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDSAbandonedSep 27, 13Apr 17, 14[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.